Delivery Order SPE2DB20D3111-SPE2DB25FA8YY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 MG auto-injector (2-pack), with a ceiling value of $2,065.70 and an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of federal pharmaceutical procurement through AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $7,489.37 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $31,845.97. This firm fixed-price delivery order, which is expected to be completed by August 12, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This contract represents a firm fixed-price delivery order with a ceiling value of $3,057.33 and an ultimate completion date of August 15, 2025. The award was made through open competition with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $2,724.24. This competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine procurement action under the pharmaceutical supply chain supporting federal medical needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack) with a ceiling value of $1,209.24 under firm fixed-price terms. This contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 12, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epinephrine 0.3 mg auto-injector auto-load (2-pack) with a ceiling value of $2,708.34. This competitively awarded, firm fixed-price delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania and is scheduled for completion by August 20, 2025. The contract carries no set-aside designation, indicating open competition among eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $3,102.72 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order with a completion date of July 23, 2025. The award is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,401.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $17,126.26. This firm fixed-price delivery order, which is not set-aside restricted, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8YYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $2,024.38. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a standard pharmaceutical supply transaction under the company's broader relationship with DLA. The award carries no set-aside designation, indicating competitive procurement among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor on this order, which was performed at the company's corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems globally, enabling the delivery of a wide range of pharmaceutical products, medical devices, vaccines, and specialty medications. The Epinephrine auto-injector delivery supports critical medical supply requirements across Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, consistent with DLA's pharmaceutical prime vendor program objectives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/19/25 |